AGE-SPECIFIC CLINICAL PRACTICE GUIDELINES FOR EARLY-ONSET BOWEL CANCER To be developed by Bowel Cancer Australia in collaboration with the Australian Living Evidence Collaboration (ALEC)
With
Dr Prasad Cooray, Medical Oncologist,
Yarra Oncology &
Clinical Researcher & Lecturer,
The University of Melbourne &
Spokesperson, Bowel Cancer Australia
SEGMENT
Filmed in Melbourne | April 2026
Each year almost 1,900 Australians are diagnosed with early-onset bowel cancer (under age 50), and they are currently managed according to clinical practice guidelines that are not age specific.
The National Health and Medical Research Council (NHMRC) has agreed to consider for approval the Clinical Practice Guidelines for the Early Diagnosis and Management of Early-Onset Colorectal Cancer (EOCRC), to be developed by Bowel Cancer Australia in collaboration with the Australian Living Evidence Collaboration (ALEC), and funded by Bowel Cancer Australia. ALEC is led by Cochrane Australia and based in the School of Public Health and Preventive Medicine at Monash University.
“Development of co-designed age-appropriate guidelines is essential given the rising rates of bowel cancer among Australians under 50 to ensure they reflect the unique clinical challenges younger people encounter,” Bowel Cancer Australia CEO Julien Wiggins said.
“The guidelines will use an established ‘living’ approach to generate up-to-date, evidence-based guidance to support clinical decision-making. As soon as new research becomes available, it can be incorporated into the guidelines and translated into clinical practice in near real-time.”
“Young Australians diagnosed with bowel cancer face a very different disease trajectory compared to older patients, yet they are managed under the same clinical framework,” Medical Oncologist and Bowel Cancer Australia spokesperson Dr Prasad Cooray, said to Australian Health Journal.
“That gap has real consequences, contributing to delayed diagnosis, more advanced stage at presentation, poorer survival outcomes, and long-term impacts on fertility, survivorship, and quality of life.
Young women are a particular concern because fertility and pregnancy can be impacted by treatment while postpartum changes can hide or confuse symptoms.
Source: Adapted from Bowel Cancer Australia media release (February 2026)
-
Role of milk in cognitive function and quality of life in older adults
New research emphasises the role of cows’ milk, particularly A1 protein free milk, in enhancing cognitive function and quality of life for older adults with mild cognitive impairment (MCI). A multi-centre, double-blinded, randomised controlled clinical study published in *The Journal of Nutrition, Health and Aging* evaluated 88 milk-tolerant Chinese adults aged 65-75 over three months. Participants consumed either ordinary skim milk or A1 protein free skim milk, leading to improvements in various cognitive assessments.
-
Dental marketing insights from leading authority
Winning the Australian Dental Industry Award for Marketing has had a big impact to Dental Marketing Solutions. As Angus comments in closing, “Receiving the award is social proof to say, well, these guys must know something, because an independent body of their peers has assessed them and said”. He added, “Certainly it’s been good in terms of building our business.”
-
Redefining diversity in clinical trials
Ensuring inclusion, diversity, equity and patient input in the development of novel drugs and medical devices has become well accepted in health care. However appropriate implementation of these elements has been a challenge for many. Only by implementing these conscious inputs can patient outcomes be improved and health disparities in marginalised groups be addressed.
Australian Health Journal spoke to Gillian Mason, Consumer and Community Involvement Lead at Hunter Medical Research Institute in Newcastle, NSW on this topic discussed at the recent ARCS Conference in Sydney.
